As of 2025-02-12, the EV/EBITDA ratio of BioLife Solutions Inc (BLFS) is -388.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLFS's latest enterprise value is 1,201.57 mil USD. BLFS's TTM EBITDA according to its financial statements is -3.09 mil USD. Dividing these 2 quantities gives us the above BLFS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 12.1x | 9.6x |
| Forward P/E multiples | 8.5x - 10.9x | 10.3x |
| Fair Price | (0.51) - (0.67) | (0.61) |
| Upside | -102.0% - -102.6% | -102.3% |
| Date | EV/EBITDA |
| 2025-02-07 | -388.73 |
| 2025-02-06 | -390.07 |
| 2025-02-05 | -397.99 |
| 2025-02-04 | -392.16 |
| 2025-02-03 | -396.49 |
| 2025-01-31 | -406.72 |
| 2025-01-30 | -412.61 |
| 2025-01-29 | -421.57 |
| 2025-01-28 | -424.41 |
| 2025-01-27 | -421.27 |
| 2025-01-24 | -413.81 |
| 2025-01-23 | -414.70 |
| 2025-01-22 | -409.18 |
| 2025-01-21 | -409.33 |
| 2025-01-17 | -389.33 |
| 2025-01-16 | -393.96 |
| 2025-01-15 | -397.84 |
| 2025-01-14 | -391.27 |
| 2025-01-13 | -401.72 |
| 2025-01-10 | -396.34 |
| 2025-01-08 | -412.47 |
| 2025-01-07 | -403.81 |
| 2025-01-06 | -406.05 |
| 2025-01-03 | -393.51 |
| 2025-01-02 | -389.93 |
| 2024-12-31 | -386.64 |
| 2024-12-30 | -391.27 |
| 2024-12-27 | -396.05 |
| 2024-12-26 | -402.61 |
| 2024-12-24 | -394.70 |
| 2024-12-23 | -392.91 |
| 2024-12-20 | -407.99 |
| 2024-12-19 | -388.88 |
| 2024-12-18 | -372.01 |
| 2024-12-17 | -400.22 |
| 2024-12-16 | -407.69 |
| 2024-12-13 | -397.69 |
| 2024-12-12 | -397.99 |
| 2024-12-11 | -392.01 |
| 2024-12-10 | -390.22 |
| 2024-12-09 | -391.27 |
| 2024-12-06 | -390.82 |
| 2024-12-05 | -375.00 |
| 2024-12-04 | -392.91 |
| 2024-12-03 | -399.33 |
| 2024-12-02 | -406.20 |
| 2024-11-29 | -409.18 |
| 2024-11-27 | -404.55 |
| 2024-11-26 | -403.06 |
| 2024-11-25 | -398.73 |